BDBM27519 4-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-13-yl}butanamide::indeno[1,2-c]isoquinolinone, 5d
SMILES: O=C(CCCN1CCOCC1)Nc1ccc2Cc3c([nH]c(=O)c4ccccc34)-c2c1
InChI Key: InChIKey=ULUOHIWKHZERBU-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27519 (4-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0....) | PDB MMDB UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 400 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair |